Bellerophon Therapeutics Inc
(BLPH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,267 | -9,187 | -4,900 | -795 | 2,814 |
| Depreciation Amortization | 348 | 263 | 176 | 88 | 362 |
| Other Working Capital | -161 | -1,049 | -1,330 | -1,025 | 3,251 |
| Other Operating Activity | 144 | -69 | -28 | -608 | -21,922 |
| Operating Cash Flow | $-12,936 | $-10,042 | $-6,082 | $-2,340 | $-15,495 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | 3,000 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $3,000 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 6,236 | 6,236 | 6,236 | 6,374 | 166 |
| Other Financing Activity | -69 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $6,167 | $6,236 | $6,236 | $6,374 | $166 |
| Beginning Cash Position | 17,046 | 17,046 | 17,046 | 17,046 | 29,375 |
| End Cash Position | 10,277 | 13,240 | 17,200 | 21,080 | 17,046 |
| Net Cash Flow | $-6,769 | $-3,806 | $154 | $4,034 | $-12,329 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,936 | -10,042 | -6,082 | -2,340 | -15,495 |
| Free Cash Flow | -12,936 | -10,042 | -6,082 | -2,340 | -15,495 |